RECENTLY, we encountered an unusual response to digitalis. A patient with rheumatic valvular disease, congestive heart failure, and atrial fibrillation exhibited simultaneously evidence regarded by some as due to underdigitalization and by others as the result of overdigitalization. During mild exertion, the ventricular rate accelerated from 70 to 140 beats per minute with development of a pulse deficit suggesting inadequate digitalization. At the same time, however, this patient developed ventricular bigeminy with multiform complexes suggesting digitalis intoxication ( fig. 1 ). In order to clarify this anomalous situation, a digitalis tolerance test was performed with acetyl strophanthidin.' The first small increment of acetyl strophanthidin provoked ventricular bigeminal rhythm ( fig.  2 ), a response consistent with digitalis overdosage. Mild exercise immediately following the test, however, again accelerated the rate to 140, a response compatible with underdigitalization. Thus the paradox of apparent coexisting evidence suggesting both overdigitalization as well as underdigitalization remained unsolved.
This patient was receiving many medications. With the exception of reserpine, which was being administered in a daily oral dose of 1.0 mg., none of the other drugs appeared likely to alter the response to digitalis. A search of the literature did not reveal significant information concerning the effects of reserpine upon the digitalized state. The present study was therefore undertaken to determine (1) action of digitalis upon atrium, atrioventrieular conduction system, and ventricle; (2) whether the carotid sinuses are unduly sensitized by the combined use of these two drugs; and (3) whether reserpine can control the ventricular rate in the partially digitalized patient with atrial fibrillation.
Material and Methods
The sensitivity of the myocardium to digitalis was tested with acetyl strophanthidin both immediately before and during the administration of reserpine. Acetyl strophanthidin is a synthetic aglycone of strophanthin. When it is given intravenously, a cardiac effect occurs within 3 minutes. Peak action develops in 12 minutes, and dissipation is complete within 2 hours.
Fifteen patients in congestive heart failure were studied. All were receiving maintenance doses of one of the long-acting digitalis preparations. Six were in normal sinus rhythm and nine had atrial fibrillation. Two of the patients with normal sinus rhythm had coronary artery disease, one rheumatic valvular disease, two cor pulmonale, and one idiopathic myocarditis. Of the patients with atrial fibrillation eight had rheumatic valvular and one had coronary artery disease.
The same experimental design was employed in each of the 15 patients. Two digitalizations were carried out in identical manner: 0.15 mg. of acetyl strophanthidin in 2.5 ml. of diluent was injected intravenously every 5 minutes until development of the earliest evidence of intoxication or the administration of a total dose of 1.2 mg. Nausea, vomiting, and a change in rhythm or in conduction constituted the toxic end-point. This schedule represents a slight modification in the use of acetyl strophanthidin from that proposed initially.' The reduction in the size of the incremental dose has enhanced the safety of such ultra-rapid digitalizations.
Immediately following the first digitalization 1 mg. of reserpine was given intramuscularly. This was continued daily for 3 days. On the third day, a second digitalization with acetyl strophanthidin was repeated. Prior to and immediately following each of the two digitalizations, the sensitivity of the heart to right carotid sinus massage was tested. This maneuver was employed to assess the cardiac 16OWN ET AL. Figure 1 Exercise accelerated ventricular rate to 140, suggesting inadequate digitalization. Simultaneous development of ventricular bigeminal rhythm indicated digitalis intoxication. response to vagus nerve stimulation when reserpine and digitalis were combined. Throughout this study there was no change in the maintenance dose of the long-acting digitalis preparations that these patients were receiving.
In addition, three of the patients with atrial fibrillation were subjected to mild exercise consisting of 10 sit-ups, accomplished before and after each of the two digitalizations.
Results

Patients with Atrial Fibrillation
Reserpine increased the toxic action of digitalis. This was clearly demonstrated in patients with atrial fibrillation. In the digitalization following reserpine, the tolerated dose of acetyl strophanthidin was reduced, the incidence or arrhythmias was increased, and the heart was more markedly slowed (table 1A) .
In five of the nine patients with atrial fibrillation, after reserpine, the tolerated dose of acetyl strophanthidin was reduced. In these five patients, the mean tolerated dose of acetyl strophanthidin was 1.1 mg. in the first and 0.5 mg. in the second digitalization. The electrocardiogram in one of these five patients is illustrated ( fig. 3 ). In the initial digitalization only one patient developed an arrhythmia before receiving the full dose of 1.2 mg. In the second digitalization, however, eight of the nine subjects exhibited toxicity consisting of complete heart block in one, nodal rhythm in three, and ventricular ectopic beats in five. In four of the five, the ventricular extrasystoles were either bigeminal or multiform. Another example of increased cardiac reactivity to acetyl strophanthidin is shown in figure 4 . In this patient during the control digitalization, 1.2 mg. of acetyl strophanthidin merely slowed the ventricular rate; following reserpine, however, an identical dose of acetyl strophanthidin induced nodal rhythm with 3:2 antegrade block below a complete atrioventricular block with periodic ventricular escape beats. This same patient illustrates the remarkable slowing in heart rate that results from the combined action of reserpine and digitalis. In the entire group of nine patients with atrial fibrillation, the mean ventricular rate was reduced from 75 to 61 in the first and from 55 to 42 to digitalization (table iB). Five of the six patients with normal sinus rhythm were digitalized twice. In none of the five was there a change in the dose of acetyl strophanthidin or in the incidence of toxic reactions following reserpine.
In order to determine whether reserpine increased the sensitivity of the heart to vagal stimulation in digitalized patients, with either sinus rhythm or atrial fibrillation, the carotid sinus on the right side was massaged on four different occasions, i.e., before and after each of the two digitalizations. Both acetyl strophanthidin and reserpine increased the cardiac response to this vagal maneuver. The most marked effect was noted when the two drugs were used together ( dueed an abnormal response in nine of the 15 subjects. In one of these patients the vagal maneuver provoked ventricular bigeminal rhythm. The carotid sinus was tested in only 11 of the patients who were digitalized after reserpine, the four remaining patients showed advanced toxic reactions from acetyl strophanthidin and were therefore not considered to be suitable candidates for this maneuver. Of the 11 patients tested, nine reacted abnormally, two exhibiting bigeminal rhythm. Since the four patients in whom carotid sinus massage was not repeated had reacted adversely to vagal stimulation before the second digitalization, it is likely that following the digitalization with acetyl strophanthidin a similar but more marked response would have occurred. Thus 13 out of the 15 patients might have shown enhanced responsiveness to the carotid maneuver after both drugs.
In the digitalized patient, reserpine promotes bradyeardia. To determine whether the slowing is maintained after exertion, three patients with atrial fibrillation were made to exercise before and after the two digitalizations. Though reserpine slowed the mean ventricular rate from 90 to 70 beats per minute 8LOWN ET AL. ventricular acceleration during exercise. The findings also indicate that reserpine sensitizes the myocardium to the induction of ectopic beats by digitalis. Since myocardial aerobic metabolism is seriously compromised during tachycardia, it seems likely that ventricular extrasystoles would be more readily produced by such drug interaction when the heart rate is rapid. In the patient with atrial fibrillation the end result may be bigeminal rhythm and a rapid ventricular rate.
Reserpine increases central parasympathetic outflow thereby augmenting vagal tone. In the present study this was demonstrated by response to carotid sinus stimulation before and after administration of reserpine. Of 15 patients tested only three had abnormal reactions to carotid sinus massage initially as contrasted to nine such reactions after pretreatment with reserpine.
It is well established that digitalization also sensitizes the heart to vagal discharge. Carotid sinus stimulation may be employed to detect overdigitalization before it becomes otherwise evident.2 The emergence in the digitalized patient of heart block, nodal rhythm, or ectopic beats during this vagal maneuver suggests incipient intoxication. It is of interest that two of the patients who developed untoward reactions during the initial carotid sinus test were unable to tolerate the full dose of acetyl strophanthidin. These two were also the only patients to develop ventricular bigeminal rhythm during the control digitalization. In Circulation, Volume XXIV, November 1961 
